Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2026

Feb 3, 2026

29745_dirs_2026-02-03_e10feef1-d572-4764-b74c-a6b2409eac71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-01

Reporting Person: Rau Diogo (EVP & CIDO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-01 Common Stock M 3752 Acquired 23470.908 Direct
2026-02-01 Common Stock F 1673.538 $1037.15 Disposed 21797.37 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-01 Restricted Stock Unit $ M 3752 Disposed 2026-02-01 Common Stock (3752) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.